The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery

Renal Failure

Volumn 30, Issue 3, 2008, Pages 303-306

  Hsu, Heng Jung ^a   Ya Chung, Tian ^a   Yung Chang, Chen ^a   Bien Chieng, Lai ^a   Ji Tsuen, Fang ^a   Wei, Yang Chih ^a,b   Wu, Mai Szu ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cyclosporine; Delayed graft function; Kidney transplantation; Sirolimus

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; STEROID;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; CYCLOSPORINE; DELAYED GRAFT FUNCTION; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SIROLIMUS;

EID: 41149123423     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701860989     Document Type: Article

References (13)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605-612.
2. Kahan BD, Chang JY, Sehgal SN. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation 1991;52:185-191.
3. Lieberthal W, Fuhro R, Andry CC, et al. Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol. 2001;281:F693-F706.
4. Smith KD, Wrenshall LE, Nicosia RF, et al. Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol. 2003;14:1037-1045.
5. McTaggart RA, Gottlieb D, Brooks J, et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003;3:416-423.
6. Davis C. Sirolimus delays renal allograft recovery. Am J Transplant. 2003;3:363-365.
7. Geddes CC, Woo YM, Jardine AG. The impact of delayed graft function on the long-term outcome of renal transplantation. J Nephrol. 2002;15:17-21.
8. Humes HD, MacKay SM, Funke AJ, Buffington DA. Acute renal failure: Growth factors, cell therapy, and gene therapy. Proc Assoc Am Physicians. 1997;109:547-557.
9. Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest. 1994;93:2175-2188.
10. Johnson RW, Kreis H, Oberbauer R, et al. Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure. Transplantation. 2001;72:777-786.
11. I. NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: update 2000. Am J Kidney Dis. 2001;37:S7-S64.
12. Oniscu GC, Brown H, Forsythe JL. How old is old for transplantation? Am J Transplant. 2004;4:2067-2074.
13. Barger BO, Hudson SL, Shroyer TW, et al. Influence of race on renal allograft survival in the pre- and post- cyclosporine era. Clin Transpl. 1987:217-233.